Literature DB >> 8957090

Molecular characterization and modular analysis of human MyD88.

G Hardiman1, F L Rock, S Balasubramanian, R A Kastelein, J F Bazan.   

Abstract

MyD88 was first characterized as a myeloid differentiation primary response gene in mice, activated in M1 myeloleukemic cells following interleukin-6 (IL-6) induced growth arrest and terminal differentiation. Analysis of expressed sequence tags (ESTs) from activated dendritic cell libraries led to the indentification of cDNAs encoding the human homolog (hMyD88). The original description of MyD88 as a 243 aa protein may reflect a truncated mouse cDNA since the 2682 nt hMyD88 cDNA predicts a 296 aa cytoplasmic protein. Consistent with this proposal is the detection of a 33 kDa protein in human heart, kidney and liver tissue. The expression pattern of MyD88 is also more widespread than originally believed: a 2.6 kb hMyD88 mRNA species was found to be constitutively expressed in many adult human tissues; in addition MyD88 expression was observed in monocyte, T, B, NK and dendritic cells. The MyD88 protein has a modular structure composed of an N-terminal 'death domain' (DD) similar to the intracellular segments of TNF receptor 1 (TNFR1) and FAS and a C-terminal region related to the signaling domains of vertebrate interleukin-1 receptors (IL-1R) and the Drosophila morphogen Toll. This intriguing structural framework may endow MyD88 with unique signaling capabilities.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957090

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Fas (CD95) induces macrophage proinflammatory chemokine production via a MyD88-dependent, caspase-independent pathway.

Authors:  William A Altemeier; Xiaodong Zhu; William R Berrington; John M Harlan; W Conrad Liles
Journal:  J Leukoc Biol       Date:  2007-06-18       Impact factor: 4.962

2.  TLR4/MyD88/PI3K interactions regulate TLR4 signaling.

Authors:  Michelle H W Laird; Sang Hoon Rhee; Darren J Perkins; Andrei E Medvedev; Wenji Piao; Matthew J Fenton; Stefanie N Vogel
Journal:  J Leukoc Biol       Date:  2009-03-16       Impact factor: 4.962

3.  Identification of critical residues of the MyD88 death domain involved in the recruitment of downstream kinases.

Authors:  Maria Loiarro; Grazia Gallo; Nicola Fantò; Rita De Santis; Paolo Carminati; Vito Ruggiero; Claudio Sette
Journal:  J Biol Chem       Date:  2009-08-13       Impact factor: 5.157

4.  Toll/interleukin-1 receptor domain dimers as the platform for activation and enhanced inhibition of Toll-like receptor signaling.

Authors:  Ota Fekonja; Mojca Benčina; Roman Jerala
Journal:  J Biol Chem       Date:  2012-07-24       Impact factor: 5.157

5.  Identification and expression of alternatively spliced novel isoforms of cancer associated MYD88 lacking death domain in mouse.

Authors:  Hassan Mubarak Ishqi; Mohammed Amir Husain; Sayeed Ur Rehman; Tarique Sarwar; Mohammad Tabish
Journal:  Mol Biol Rep       Date:  2018-06-14       Impact factor: 2.316

6.  The apoptotic signaling pathway activated by Toll-like receptor-2.

Authors:  A O Aliprantis; R B Yang; D S Weiss; P Godowski; A Zychlinsky
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

7.  A family of human receptors structurally related to Drosophila Toll.

Authors:  F L Rock; G Hardiman; J C Timans; R A Kastelein; J F Bazan
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

Review 8.  Targeting TLR/IL-1R signalling in human diseases.

Authors:  Maria Loiarro; Vito Ruggiero; Claudio Sette
Journal:  Mediators Inflamm       Date:  2010-04-08       Impact factor: 4.711

9.  Toll/Interleukin-1 Receptor Domain Derived from TcpC (TIR-TcpC) Ameliorates Experimental Autoimmune Arthritis by Down-modulating Th17 Cell Response.

Authors:  Shweta Pasi; Ravi Kant; Avadhesha Surolia
Journal:  J Biol Chem       Date:  2016-03-28       Impact factor: 5.157

10.  Site-specific biotinylation of human myeloid differentiation protein 88 in Drosophila melanogaster Schneider 2 cell cytoplasm.

Authors:  G Basile; M Peticca; S Catello
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.